Wuhan

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Amyloidosis1 trial
• High blood pressure1 trial
• Neuromyelitis optica (NMOSD)1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Alnylam Pharmaceuticals2 trials
• Alexion Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  NCT05966467· Alexion Pharmaceuticals, Inc.· Source

  Contact: Daishi Tian, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis1 recruiting
• High blood pressure1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting